Karachi: Citi Pharma Limited has announced the resignation of its Chief Financial Officer, Mr. Salman Anwar Malik, effective August 7, 2026. The acting charge of the CFO position has been assigned to Mr. Hanan Alam, who is currently serving as the Financial Controller of the company. According to information available from the Pakistan Stock Exchange (PSX), this change in the executive position is expected to be communicated to the TRE Certificate Holders of the exchange.

The leadership transition comes as Mr. Malik steps down from his role in the company. Mr. Alam’s appointment as the interim CFO is intended to ensure continuity in the financial management of Citi Pharma Limited. The company has not specified a timeline for appointing a permanent successor to Mr. Malik.

Citi Pharma Limited operates within the pharmaceutical sector, which is a designated market category under the Pakistan Stock Exchange. The company has not provided further details regarding the reasons for Mr. Malik’s resignation or any strategic shifts that might accompany this change in leadership. The appointment of Mr. Alam as the acting CFO is seen as a move to maintain stability in the company's financial operations during this period of transition.